Kieren A. Marr

60.2k total citations · 12 hit papers
220 papers, 31.4k citations indexed

About

Kieren A. Marr is a scholar working on Infectious Diseases, Epidemiology and Oncology. According to data from OpenAlex, Kieren A. Marr has authored 220 papers receiving a total of 31.4k indexed citations (citations by other indexed papers that have themselves been cited), including 187 papers in Infectious Diseases, 162 papers in Epidemiology and 34 papers in Oncology. Recurrent topics in Kieren A. Marr's work include Antifungal resistance and susceptibility (173 papers), Fungal Infections and Studies (135 papers) and Pneumocystis jirovecii pneumonia detection and treatment (30 papers). Kieren A. Marr is often cited by papers focused on Antifungal resistance and susceptibility (173 papers), Fungal Infections and Studies (135 papers) and Pneumocystis jirovecii pneumonia detection and treatment (30 papers). Kieren A. Marr collaborates with scholars based in United States, South Africa and United Kingdom. Kieren A. Marr's co-authors include Thomas J. Walsh, Raleigh A. Bowden, Theodore C. White, William J. Steinbach, S. Arunmozhi Balajee, Lawrence Corey, Michael Boeckh, Rachel A. Carter, David R. Andes and Peter G. Pappas and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Investigation and Journal of Clinical Oncology.

In The Last Decade

Kieren A. Marr

218 papers receiving 30.7k citations

Hit Papers

Clinical Practice Guideline for t... 1998 2026 2007 2016 2015 2008 2016 2002 1998 500 1000 1.5k 2.0k 2.5k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America
    2015 2.6k citations David R. Andes, Kieren A. Marr et al. Clinical Infectious Diseases profile →
  2. Treatment of Aspergillosis: Clinical Practice Guidelines of the Infectious Diseases Society of America
    2008 1.9k citations David W. Denning, Raoul Herbrecht et al. Clinical Infectious Diseases profile →
  3. Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America
    2016 1.8k citations Thomas F. Patterson, David W. Denning et al. Clinical Infectious Diseases profile →
  4. Epidemiology and Outcome of Mould Infections in Hematopoietic Stem Cell Transplant Recipients
    2002 1.1k citations Kieren A. Marr et al. Clinical Infectious Diseases profile →
  5. Clinical, Cellular, and Molecular Factors That Contribute to Antifungal Drug Resistance
    1998 1.1k citations Kieren A. Marr et al. profile →
  6. Reduced Mortality after Allogeneic Hematopoietic-Cell Transplantation
    2010 1.0k citations Kieren A. Marr et al. profile →
  7. Executive Summary: Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America
    2016 979 citations David R. Andes, Kieren A. Marr et al. Clinical Infectious Diseases profile →
  8. Epidemiology and Outcomes of Candidemia in 2019 Patients: Data from the Prospective Antifungal Therapy Alliance Registry
    2009 732 citations Dionysios Neofytos, Kieren A. Marr et al. Clinical Infectious Diseases profile →
  9. Invasive aspergillosis in allogeneic stem cell transplant recipients: changes in epidemiology and risk factors
    2002 726 citations Kieren A. Marr et al. profile →
  10. Epidemiology and Outcome of Invasive Fungal Infection in Adult Hematopoietic Stem Cell Transplant Recipients: Analysis of Multicenter Prospective Antifungal Therapy (PATH) Alliance Registry
    2008 603 citations Dionysios Neofytos, Kieren A. Marr et al. Clinical Infectious Diseases profile →
  11. Voriconazole Treatment for Less‐Common, Emerging, or Refractory Fungal Infections
    2003 508 citations Kieren A. Marr, Richard N. Greenberg et al. Clinical Infectious Diseases profile →
  12. Combination Antifungal Therapy for Invasive Aspergillosis
    2015 333 citations Kieren A. Marr, Raoul Herbrecht et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kieren A. Marr United States 79 24.1k 20.9k 3.8k 3.0k 2.7k 220 31.4k
Dimitrios P. Kontoyiannis United States 98 29.7k 1.2× 24.5k 1.2× 4.1k 1.1× 3.9k 1.3× 2.7k 1.0× 604 38.8k
Oliver A. Cornely Germany 72 16.5k 0.7× 14.2k 0.7× 3.2k 0.9× 1.6k 0.5× 1.6k 0.6× 546 21.3k
Raoul Herbrecht France 64 13.0k 0.5× 11.3k 0.5× 5.6k 1.5× 2.1k 0.7× 2.3k 0.8× 303 22.5k
Johan Maertens Belgium 66 12.6k 0.5× 12.2k 0.6× 4.0k 1.1× 1.8k 0.6× 1.7k 0.6× 384 20.2k
Olivier Lortholary France 79 16.3k 0.7× 15.9k 0.8× 1.6k 0.4× 1.8k 0.6× 1.4k 0.5× 482 23.6k
Peter G. Pappas United States 73 24.4k 1.0× 21.8k 1.0× 2.1k 0.5× 1.9k 0.6× 1.9k 0.7× 242 29.9k
Carol A. Kauffman United States 78 20.5k 0.9× 17.7k 0.8× 1.4k 0.4× 1.7k 0.6× 1.8k 0.7× 364 27.5k
Thomas F. Patterson United States 65 16.3k 0.7× 13.7k 0.7× 1.6k 0.4× 2.5k 0.8× 1.9k 0.7× 262 19.7k
John R. Wingard United States 84 13.7k 0.6× 14.1k 0.7× 9.5k 2.5× 1.6k 0.5× 3.4k 1.2× 438 33.4k
Jacques F. Meis Netherlands 88 24.9k 1.0× 20.5k 1.0× 1.5k 0.4× 3.5k 1.1× 2.1k 0.8× 685 33.8k

Countries citing papers authored by Kieren A. Marr

Since Specialization
Citations

This map shows the geographic impact of Kieren A. Marr's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kieren A. Marr with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kieren A. Marr more than expected).

Fields of papers citing papers by Kieren A. Marr

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kieren A. Marr. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kieren A. Marr. The network helps show where Kieren A. Marr may publish in the future.

Co-authorship network of co-authors of Kieren A. Marr

This figure shows the co-authorship network connecting the top 25 collaborators of Kieren A. Marr. A scholar is included among the top collaborators of Kieren A. Marr based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kieren A. Marr. Kieren A. Marr is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Permpalung, Nitipong, Kieren A. Marr, Kausik Datta, et al.. (2023). 615. A Prospective Cohort Study to Evaluate Performance of MycoMEIA – Aspergillus: A New Urine Diagnostic for Aspergillosis. Open Forum Infectious Diseases. 10(Supplement_2). 2 indexed citations
2.
Nematollahi, Saman, Sean Tackett, Suzanne M. Grieb, et al.. (2023). Teaching Everyone Everywhere All at Once: Leveraging Social Media to Implement a Multisite Fungal Diagnostics Curriculum. Open Forum Infectious Diseases. 10(12). ofad594–ofad594. 1 indexed citations
3.
Bennett, John E., et al.. (2023). Neuroimaging of Cryptococcal Meningitis in Patients without Human Immunodeficiency Virus: Data from a Multi-Center Cohort Study. Journal of Fungi. 9(5). 594–594. 11 indexed citations
4.
Permpalung, Nitipong, Teresa Po‐Yu Chiang, Robin K. Avery, et al.. (2023). Coronavirus Disease 2019–Associated Pulmonary Aspergillosis: A Noninvasive Screening Model for Additional Diagnostics. Open Forum Infectious Diseases. 10(4). ofad155–ofad155. 3 indexed citations
5.
Permpalung, Nitipong, Tao Liang, Darin Ostrander, et al.. (2023). Invasive fungal infections after respiratory viral infections in lung transplant recipients are associated with lung allograft failure and chronic lung allograft dysfunction within 1 year. The Journal of Heart and Lung Transplantation. 42(7). 953–963. 5 indexed citations
6.
Aerts, Robina, Kausik Datta, Kieren A. Marr, & Johan Maertens. (2022). Urine Aspergillus Antigen Detection to Screen for Invasive Aspergillosis in at-Risk Patients Treated for Hematologic Malignancies. Transplantation and Cellular Therapy. 28(3). S46–S46. 1 indexed citations
7.
Datta, Kausik, Nitipong Permpalung, Sukanya Das, et al.. (2022). Development of an Interferon-Gamma Release Assay (IGRA) to Aid Diagnosis of Histoplasmosis. Journal of Clinical Microbiology. 60(10). e0112822–e0112822. 4 indexed citations
8.
Golden, Sherita Hill, Eric B Bass, Stephen A. Berry, et al.. (2018). Building Leadership Capacity for Mission Execution in a Large Academic Department of Medicine. The American Journal of Medicine. 132(4). 535–543.
9.
Bahr, Nathan C., Anil A. Panackal, Michelle Durkin, et al.. (2018). Cryptococcal meningitis is a cause for cross‐reactivity in cerebrospinal fluid assays for anti‐Histoplasma, anti‐Coccidioides and anti‐Blastomyces antibodies. Mycoses. 62(3). 268–273. 6 indexed citations
10.
Maertens, Johan, Thomas F. Patterson, Galia Rahav, et al.. (2015). Phase 3 Randomized, Double-Blind Trial Evaluating Isavuconazole vs. Voriconazole for Primary Treatment of Invasive Fungal Disease Caused by Aspergillus Spp. or Other Filamentous Fungi (SECURE). Mycoses. 58. 196–196. 4 indexed citations
11.
Alonso, Carolyn D., David B. Hanna, Carol Ann Huff, et al.. (2012). Epidemiology and Outcomes of Clostridium difficile Infections in Hematopoietic Stem Cell Transplant Recipients. Clinical Infectious Diseases. 54(8). 1053–1063. 149 indexed citations
12.
Datta, Kausik, et al.. (2011). Cystic Fibrosis Transmembrane Conductance Regulator Regulates Epithelial Cell Response to Aspergillus and Resultant Pulmonary Inflammation. American Journal of Respiratory and Critical Care Medicine. 185(3). 301–310. 66 indexed citations
13.
Limper, Andrew H., Kenneth S. Knox, George A. Sarosi, et al.. (2010). An Official American Thoracic Society Statement: Treatment of Fungal Infections in Adult Pulmonary and Critical Care Patients. American Journal of Respiratory and Critical Care Medicine. 183(1). 96–128. 399 indexed citations
14.
Kontoyiannis, Dimitrios P., V. Ratanatharathorn, Jo‐Anne H. Young, et al.. (2008). Micafungin alone or in combination with other systemic antifungal therapies in hematopoietic stem cell transplant recipients with invasive aspergillosis. Transplant Infectious Disease. 11(1). 89–93. 75 indexed citations
15.
García‐Vidal, Carolina, Arlo Upton, Katharine A. Kirby, & Kieren A. Marr. (2008). Epidemiology of Invasive Mold Infections in Allogeneic Stem Cell Transplant Recipients: Biological Risk Factors for Infection According to Time after Transplantation. Clinical Infectious Diseases. 47(8). 1041–1050. 280 indexed citations
16.
Panackal, Anil A., et al.. (2006). Clinical Significance of Azole Antifungal Drug Cross-Resistance in Candida glabrata. Journal of Clinical Microbiology. 44(5). 1740–1743. 107 indexed citations
17.
Greenberg, Richard N., Kathleen M. Mullane, Issam Raad, et al.. (2005). Posaconazole as Salvage Therapy for Zygomycosis. Antimicrobial Agents and Chemotherapy. 50(1). 126–133. 407 indexed citations
18.
Balajee, S. Arunmozhi, et al.. (2005). Aspergillus lentulus sp. nov., a New Sibling Species of A. fumigatus. Eukaryotic Cell. 4(3). 625–632. 307 indexed citations
19.
Bok, Jin Woo, S. Arunmozhi Balajee, Kieren A. Marr, et al.. (2005). LaeA, a Regulator of Morphogenetic Fungal Virulence Factors. Eukaryotic Cell. 4(9). 1574–1582. 225 indexed citations
20.
Imhof, Alexander, S. Arunmozhi Balajee, David N. Fredricks, J. A. Englund, & Kieren A. Marr. (2004). Breakthrough Fungal Infections in Stem Cell Transplant Recipients Receiving Voriconazole. Clinical Infectious Diseases. 39(5). 743–746. 298 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Dimitrios P. Kontoyiannis Breakdown of academic impact, for papers by Oliver A. Cornely Breakdown of academic impact, for papers by Raoul Herbrecht Breakdown of academic impact, for papers by Johan Maertens Breakdown of academic impact, for papers by Olivier Lortholary Breakdown of academic impact, for papers by Peter G. Pappas Breakdown of academic impact, for papers by Carol A. Kauffman Breakdown of academic impact, for papers by Thomas F. Patterson Breakdown of academic impact, for papers by John R. Wingard Breakdown of academic impact, for papers by Jacques F. Meis
Rankless by CCL
2026